225 related articles for article (PubMed ID: 15650041)
1. A subfertile patient diagnosed with testicular carcinoma in situ by immunocytological staining for AP-2gamma in semen samples: case report.
Hoei-Hansen CE; Rajpert-De Meyts E; Carlsen E; Almstrup K; Leffers H; Skakkebaek NE
Hum Reprod; 2005 Mar; 20(3):579-82. PubMed ID: 15650041
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors.
Hoei-Hansen CE; Nielsen JE; Almstrup K; Sonne SB; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Clin Cancer Res; 2004 Dec; 10(24):8521-30. PubMed ID: 15623634
[TBL] [Abstract][Full Text] [Related]
3. Application of stem cell markers in search for neoplastic germ cells in dysgenetic gonads, extragonadal tumours, and in semen of infertile men.
Hoei-Hansen CE
Cancer Treat Rev; 2008 Jun; 34(4):348-67. PubMed ID: 18289797
[TBL] [Abstract][Full Text] [Related]
4. Screening of subfertile men for testicular carcinoma in situ by an automated image analysis-based cytological test of the ejaculate.
Almstrup K; Lippert M; Mogensen HO; Nielsen JE; Hansen JD; Daugaard G; Jørgensen N; Foged NT; Skakkebaek NE; Rajpert-De Meyts E
Int J Androl; 2011 Aug; 34(4 Pt 2):e21-30; discussion e30-1. PubMed ID: 21696398
[TBL] [Abstract][Full Text] [Related]
5. Towards a non-invasive method for early detection of testicular neoplasia in semen samples by identification of fetal germ cell-specific markers.
Hoei-Hansen CE; Carlsen E; Jorgensen N; Leffers H; Skakkebaek NE; Rajpert-De Meyts E
Hum Reprod; 2007 Jan; 22(1):167-73. PubMed ID: 16920726
[TBL] [Abstract][Full Text] [Related]
6. Stem cell factor as a novel diagnostic marker for early malignant germ cells.
Stoop H; Honecker F; van de Geijn GJ; Gillis AJ; Cools MC; de Boer M; Bokemeyer C; Wolffenbuttel KP; Drop SL; de Krijger RR; Dennis N; Summersgill B; McIntyre A; Shipley J; Oosterhuis JW; Looijenga LH
J Pathol; 2008 Sep; 216(1):43-54. PubMed ID: 18566970
[TBL] [Abstract][Full Text] [Related]
7. A novel double staining strategy for improved detection of testicular carcinoma in situ cells in human semen samples.
Nielsen JE; Kristensen DM; Almstrup K; Jørgensen A; Olesen IA; Jacobsen GK; Horn T; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Andrologia; 2012 Apr; 44(2):78-85. PubMed ID: 21486421
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive detection of testicular carcinoma in situ in semen using OCT3/4.
van Casteren NJ; Stoop H; Dohle GR; de Wit R; Oosterhuis JW; Looijenga LH
Eur Urol; 2008 Jul; 54(1):153-8. PubMed ID: 17996359
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological and clinical aspects of carcinoma in situ of the testis.
Giwercman A; von der Maase H; Skakkebaek NE
Eur Urol; 1993; 23(1):104-10; discussion 111-4. PubMed ID: 8477770
[TBL] [Abstract][Full Text] [Related]
10. Current approaches for detection of carcinoma in situ testis.
Hoei-Hansen CE; Olesen IA; Jorgensen N; Carlsen E; Holm M; Almstrup K; Leffers H; Rajpert-De Meyts E
Int J Androl; 2007 Aug; 30(4):398-404; discussion 404-5. PubMed ID: 17705812
[TBL] [Abstract][Full Text] [Related]
11. Testicular carcinoma in situ in subfertile Danish men.
Olesen IA; Hoei-Hansen CE; Skakkebaek NE; Petersen JH; Rajpert-De Meyts E; Jørgensen N
Int J Androl; 2007 Aug; 30(4):406-11; discussion 412. PubMed ID: 17705813
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours.
de Jong J; Stoop H; Dohle GR; Bangma CH; Kliffen M; van Esser JW; van den Bent M; Kros JM; Oosterhuis JW; Looijenga LH
J Pathol; 2005 Jun; 206(2):242-9. PubMed ID: 15818593
[TBL] [Abstract][Full Text] [Related]
13. AP-2gamma protein expression in intratubular germ cell neoplasia of testis.
Hong SM; Frierson HF; Moskaluk CA
Am J Clin Pathol; 2005 Dec; 124(6):873-7. PubMed ID: 16416736
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma in situ of the testis. Detection of malignant germ cells in seminal fluid by means of in situ hybridization.
Giwercman A; Hopman AH; Ramaekers FC; Skakkebaek NE
Am J Pathol; 1990 Mar; 136(3):497-502. PubMed ID: 2316622
[TBL] [Abstract][Full Text] [Related]
15. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects.
Rajpert-De Meyts E
Hum Reprod Update; 2006; 12(3):303-23. PubMed ID: 16540528
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of markers M2A, OCT3/4, AP-2gamma, PLAP and c-KIT in the detection of extragonadal seminomas.
Biermann K; Klingmüller D; Koch A; Pietsch T; Schorle H; Büttner R; Zhou H
Histopathology; 2006 Sep; 49(3):290-7. PubMed ID: 16918976
[TBL] [Abstract][Full Text] [Related]
17. Screening for intratubular germ cell neoplasia of the testis using OCT4 immunohistochemistry.
Jones TD; MacLennan GT; Bonnin JM; Varsegi MF; Blair JE; Cheng L
Am J Surg Pathol; 2006 Nov; 30(11):1427-31. PubMed ID: 17063084
[TBL] [Abstract][Full Text] [Related]
18. Value of testicular biopsy in diagnosing carcinoma in situ testis.
Berthelsen JG; Skakkebaek NE
Scand J Urol Nephrol; 1981; 15(3):165-8. PubMed ID: 7323735
[TBL] [Abstract][Full Text] [Related]
19. Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: defining a high risk group.
Harland SJ; Cook PA; Fossa SD; Horwich A; Mead GM; Parkinson MC; Roberts JT; Stenning SP
J Urol; 1998 Oct; 160(4):1353-7. PubMed ID: 9751353
[TBL] [Abstract][Full Text] [Related]
20. [Early detection of a contralateral second carcinoma in patients with testicular tumors caused by testicular carcinoma in situ].
Kleinschmidt K; Weissbach L; Holstein AF
Urologe A; 1989 Sep; 28(5):281-4. PubMed ID: 2573191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
